Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.025 HKD | +4.17% | +13.64% | -54.55% |
Mar. 28 | China NT Pharma Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 15 | China NT Pharma Group Company Limited Announces Directorate Changes | CI |
Sales 2021 | 227M 31.29M 245M | Sales 2022 | 207M 28.58M 224M | Capitalization | 151M 20.89M 164M |
---|---|---|---|---|---|
Net income 2021 | -150M -20.7M -162M | Net income 2022 | -66M -9.11M -71.33M | EV / Sales 2021 | 4.11 x |
Net Debt 2021 | 823M 114M 889M | Net Debt 2022 | 821M 113M 887M | EV / Sales 2022 | 4.69 x |
P/E ratio 2021 |
-0.73
x | P/E ratio 2022 |
-2.27
x | Employees | 16 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 47.19% |
1 day | +4.17% | ||
1 week | +13.64% | ||
Current month | +13.64% | ||
1 month | -24.24% | ||
3 months | -48.98% | ||
6 months | -68.75% | ||
Current year | -54.55% |
Managers | Title | Age | Since |
---|---|---|---|
Tit Ng
CEO | Chief Executive Officer | 60 | 94-12-31 |
Jing Fang
DFI | Director of Finance/CFO | 55 | 19-05-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yu Biao Zhao
BRD | Director/Board Member | 54 | 19-12-30 |
Tit Ng
CEO | Chief Executive Officer | 60 | 94-12-31 |
Yu Chin
FOU | Founder | 60 | 94-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 117 M€ | +0.68% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.025 | +4.17% | 3,321,000 |
24-04-23 | 0.024 | +4.35% | 12,662,500 |
24-04-22 | 0.023 | +9.52% | 3,155,000 |
24-04-19 | 0.021 | -4.55% | 717,500 |
24-04-18 | 0.022 | +4.76% | 2,331,500 |
Delayed Quote Hong Kong S.E., April 24, 2024 at 04:08 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-54.55% | 8.09M | |
+17.97% | 42.77B | |
+20.21% | 22.23B | |
+13.12% | 14.44B | |
+12.19% | 13.05B | |
+35.45% | 11.59B | |
-8.80% | 6.95B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+6.29% | 4.97B |
- Stock Market
- Equities
- 1011 Stock